2025 U.S. Life Sciences Report
Nearly half of tracked US life sciences markets saw negative net absorption, but biotech R&D employment rose 3%+ in 2024 to an all-time high; long-term fundamentals remain strong.
Published by Colliers. Global Real Estate Intelligence links to the original source and credits the publisher; all rights remain with them.